Asia Pacific Smart Inhalers Market to Reach US$ 1,539.97 Mn at a CAGR of 27.2% in 2027 | The Insight Partners

Asia Pacific Smart Inhalers Market to 2027 - Regional Analysis and Forecasts by Product (Nebulizers and Inhalers); Disorder (Chronic Obstructive Pulmonary Disease (COPD), and Asthma); End User (Home-Care Settings and Hospitals & Clinics), and Country

Publication Month: Oct 2019 | Report Code: TIPRE00007070 | No. of Pages: 108 | Category: Medical Device | Status: Published

The Asia Pacific smart inhalers market is expected to reach US$ 1,539.97 Mn in 2027 from US$ 186.63 Mn in 2018. The market is estimated to grow with a CAGR of 27.2% from 2019-2027.

The growth of the market is driven by the factors such as, 
growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition. However, the market is likely to get impacted due to risks associated with cyber threats limited knowledge regarding the use of smart inhalers.

 

With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Asia Pacific. Some of the factors leading to growth in the number of asthma and COPD cases across the Asia Pacific are a rise in air pollution levels and increasing smoking habits.

The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into the lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. In 2016 Among the 2.2 million air pollution-related deaths in Asia pacific region, 29% were due to heart disease, 27% stroke, 22% chronic obstructive pulmonary disease, 14% lung cancer and 8% pneumonia. Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a largest contributor of the climate change. In 2017 World Health Organization (WHO) held a member states consultation on addressing the health impact of air pollution in the western pacific region, and continues to take steps to improve the situation. Children living near roads with heavy-duty vehicle traffic have twice the risk of respiratory problems as those living near less congested streets. Hence, the rising levels of air pollution coupled is anticipated to drive the demand for smart inhalers market during the forecast period

 

In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product. The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma. The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

 

China is expected to lead the market in the Asia Pacific region because the growing prevalence of asthma and COPD Across the country. According to the recent report published in the Lancet, Approximately 9% of china’s adult population about to 100 million people are suffering with chronic obstructive pulmonary disease (COPD). Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

 

Exhibit: Rest of Asia Pacific Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

 

 

ASIA PACIFIC SMART INHALERS – MARKET SEGMENTATION

 

By Product

  • Inhalers
  • Nebulizers

 

By Disorder

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

 

By End User

  • Home-care Settings
  • Hospitals & Clinics

 

By Geography

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia

Company Profiles

  • GlaxoSmithKline plc
  • Adherium Ltd.
  • Vectura Group plc
  • Novartis AG
  • Findair Sp. z o. o.
  • Cohero Health
  • Crux Product Design Ltd
  • Teva Pharmaceuticals
  • 3M
  • Amiko Digital Health Limited

 

1.              Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

2.              Asia Pacific Smart Inhalers Market –  Key Takeaways

3.              Asia Pacific Smart Inhalers Market –  Market Landscape

3.1       Overview

3.2       Market Segmentation

3.2.1       Asia Pacific Smart Inhalers Market – By Product

3.2.2       Asia Pacific Smart Inhalers Market – By Disorder

3.2.3       Asia Pacific Smart Inhalers Market – By End User

3.2.4       Asia Pacific Smart Inhalers Market – By Asia Pacific Region

3.3       PEST Analysis

4.              Asia Pacific Smart Inhalers Market – Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Increasing Levels of Air Pollution as well as Rise in the Smoking Habits

4.1.2       Rising Prevalence of Asthma and COPD Across the Asia Pacific

4.1.3       Growing Geriatric Population

4.2       Key Market Restraints

4.2.1       Risks Associated with Cyber Threats

4.2.2       Limited Knowledge Regarding the Use of Smart Inhalers

4.3       Key Market Opportunity

4.3.1       Growth in the Global Healthcare Market

4.4       Future Trend

4.4.1       Increasing Acceptance of Mobile Health Technology

4.5       Impact Analysis

5.              Smart Inhalers Market – Asia Pacific Analysis

5.1       Asia Pacific Smart Inhalers Market Revenue Forecasts And Analysis

5.2       Performance Of Key Players

6.              Smart Inhalers Market Analysis And Forecasts To 2027 – Product

6.1       Overview

6.2       Asia Pacific Smart Inhalers Market Share By PRODUCT 2018 & 2027 (%)

6.3       Inhalers Market

6.3.1       Overview

6.3.2       Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

6.4       Nebulizers Market

6.4.1       Overview

6.4.2       Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)

7.              Smart Inhalers Market Analysis And Forecasts To 2027 – Disorder

7.1       Overview

7.2       Asia Pacific Smart Inhalers Market Share By Application 2018 & 2027 (%)

7.3       Asthma Diabetes

7.3.1       Overview

7.3.2       Asthma Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Chronic Obstructive Pulmonary Disease Market

7.4.1       Overview

7.4.2       Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)

8.              Smart Inhalers Market Analysis And Forecasts To 2027 –End User

8.1       Overview

8.2       Asia Pacific Smart Inhalers Market Share By End User 2018 & 2027 (%)

8.3       Hospitals & Clinics Market

8.3.1       Overview

8.3.2       Hospitals & Clinics Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Home Care Settings Market

8.4.1       Overview

8.4.2       Home-Care Settings Market Revenue and Forecast to 2027 (US$ Mn)

9.              Smart Inhalers Market Revenue And Forecasts To 2027 – Asia Pacific Analysis

9.1       Asia Pacific Smart inhalers Market Revenue and Forecasts to 2027

9.1.1       Asia Pacific Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.2       Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.3       Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.4       Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5       Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

9.1.6       Japan Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1    Japan Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2    Japan Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.6.3    Japan Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.6.4    Japan Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7       China Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1    China Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2    China Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.7.3    China Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.7.4    China Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8       India Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1    India Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2    India Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.8.3    India Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.8.4    India Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.9       South Korea Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.1    South Korea Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.2    South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.9.3    South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.9.4    South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.10    Australia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.10.1  Australia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.10.2  Australia Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.10.3  Australia Smart Inhalers Market Revenue And Forecasts to 2027, By Disorder (US$ Mn)

9.1.10.4  Australia Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.           Smart Inhalers Market– Industry Landscape

10.1    Overview

10.2    Comparative Company Analysis

10.3    Growth Strategies Done By The Companies In The Market, (%)

10.4    Organic Developments

10.4.1    Overview

10.5    Inorganic Developments

10.5.1    Overview

11.           Smart Inhalers Market–Key Company Profiles

11.1    Glaxosmithkline Plc.

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Product Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2    Adherium Limited

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Financial Overview

11.2.4    Product Portfolio

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    Novartis AG

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Overview

11.3.4    Product Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    Vectura Group Plc

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Overview

11.4.4    Product Portfolio

11.4.5    SWOT Analysis

11.4.6    Key Developments

11.5    Cohero Health, Inc.

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Financial Overview

11.5.4    Product Portfolio

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    Crux Product Design Ltd

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial Information

11.6.4    Product Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Findair Sp. Z O. O.

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Product Portfolio

11.7.5    SWOT Analysis

11.7.6    Key Developments

11.8    Teva Pharmaceutical Industries Ltd.

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Overview

11.8.4    Product Portfolio

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    3M

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Financial Overview

11.9.4    Product Portfolio

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  Amiko Digital Health Limited

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12.           Appendix

12.1    About The Insight Partners

12.2    Glossary Of Terms


LIST OF TABLES

Table 1.            Total Number Of Persons Aged 60 Years Or Above By Region, 2017 & 2050

Table 2.            Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 3.            Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By disorder (US$ Mn)

Table 4.            Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 5.            Japan Smart Inhalers Market Revenue And Forecasts to 2027, By product (US$ Mn)

Table 6.            Japan Smart Inhalers Market Revenue And Forecasts to 2027, By disorder (US$ Mn)

Table 7.            Japan Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 8.            China Smart Inhalers Market Revenue And Forecasts to 2027, By product (US$ Mn)

Table 9.            China Smart Inhalers Market Revenue And Forecasts to 2027, By disorder (US$ Mn)

Table 10.         China Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 11.         India Smart Inhalers Market Revenue And Forecasts to 2027, By product (US$ Mn)

Table 12.         India Smart Inhalers Market Revenue And Forecasts to 2027, By disorder (US$ Mn)

Table 13.         India Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 14.         South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By product (US$ Mn)

Table 15.         South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By disorder (US$ Mn)

Table 16.         South Korea Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 17.         Australia Smart Inhalers Market Revenue And Forecasts to 2027, By product (US$ Mn)

Table 18.         Australia Smart Inhalers Market Revenue And Forecasts to 2027, By disorder (US$ Mn)

Table 19.         Australia Smart Inhalers Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 20.         Organic Developments Done By Companies

Table 21.         Inorganic Developments Done By Companies

Table 22.         Glossary Of Terms, Smart Inhalers Market


LIST OF FIGURES

Figure 1.          China Smart Inhalers Market, Revenue (US$ Mn), 2018 & 2027

Figure 2.          Asia Pacific Smart Inhalers Market By Product, Market Share (%), 2018

Figure 3.          Asia Pacific Smart Inhalers Market By Disorder, Market Share (%), 2018

Figure 4.          Asia Pacific Smart Inhalerss Market By End User, Market Share (%), 2018

Figure 5.          Smart Inhalers Market Segmentation

Figure 6.          Asia Pacific PEST Analysis

Figure 7.          Global Smart Inhalers Market Impact Analysis Of Driver And Restraints

Figure 8.          Asia Pacific Smart Inhalers Market – Revenue Forecasts And Analysis –2018- 2027

Figure 9.          Market Positioning Of Key Player In Asia Pacific Smart Inhalers Market

Figure 10.       Asia Pacific Smart Inhalers Market Share By Product 2018 & 2027 (%)

Figure 11.       Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       Asia Pacific Smart Inhalers Market Share By Application 2018 & 2027 (%)

Figure 14.       Asthma Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.       Chronic Obstructive Pulmonary Disease Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       Asia Pacific Smart Inhalers Market Share By End User 2018 & 2027 (%)

Figure 17.       Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.       Home-Care Settings Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Asia Pacific Smart inhalers Market Revenue overview, by Country, 2018 (US$ MN)

Figure 20.       Asia Pacific Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       Asia Pacific Smart Inhalers Market Revenue And Forecasts to 2027, By Country (%)

Figure 22.       Japan Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       China Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.       India Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       South Korea Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       Australia Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       Comparative Company Analysis

Figure 28.       Growth Strategies done by the companies in the Market, (%)

 

The List of Companies

 

  1. GlaxoSmithKline plc
  2. Adherium Ltd.
  3. Vectura Group plc
  4. Novartis AG
  5. Findair Sp. z o. o.
  6. Cohero Health
  7. Crux Product Design Ltd
  8. Teva Pharmaceuticals
  9. 3M
  10. Amiko Digital Health Limited

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific smart inhalers market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific smarts inhaler Market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth the Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.